May 7, 2021 Breda, the Netherlands – argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced that it will host a conference call and audio webcast on Friday, May 14, 2021 at 2:30 p.m. CET to discuss its first quarter 2021 financial results and provide a business update.